A gene sets approach for identifying prognostic gene signatures for outcome prediction

BMC Genomics

Volumn 9, Issue , 2008, Pages

  Kim, Seon Young ^a   Kim, Yong Sung ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ARTICLE; BREAST CANCER; CANCER GRADING; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE; MOLECULAR BIOLOGY; OUTCOME ASSESSMENT; PREDICTION; PROGNOSIS; TUMOR VOLUME; VALIDATION PROCESS; BIOLOGY; BREAST TUMOR; COMPARATIVE STUDY; GENE; GENETICS; METHODOLOGY; SURVIVAL;

BREAST NEOPLASMS; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENES; HUMANS; SURVIVAL ANALYSIS;

EID: 42949113503     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-9-177     Document Type: Article

References (56)

1. van de Vijver MJ He YD van't Veer LJ Dai H Hart AA Voskuil DW Schreiber GJ Peterse JL Roberts C Marton MJ A gene-expression signature as a predictor of survival in breast cancer. The New England journal of medicine 2002, 347(25):1999-2009. 10.1056/NEJMoa021967 12490681
2. Wang Y Klijn JG Zhang Y Sieuwerts AM Look MP Yang F Talantov D Timmermans M Meijer-van Gelder ME Yu J Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005, 365(9460):671-679. 15721472
3. Chang HY Sneddon JB Alizadeh AA Sood R West RB Montgomery K Chi JT van de Rijn M Botstein D Brown PO Gene expression signature of fibroblast serum response predicts human cancer progression: Similarities between tumors and wounds. PLoS biology 2004, 2(2):E7. 314300 14737219 10.1371/ journal.pbio.0020007
4. Alizadeh AA Eisen MB Davis RE Ma C Lossos IS Rosenwald A Boldrick JC Sabet H Tran T Yu X Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403(6769):503-511. 10.1038/35000501 10676951
5. Buyse M Loi S van't Veer L Viale G Delorenzi M Glas AM d'Assignies MS Bergh J Lidereau R Ellis P Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. Journal of the National Cancer Institute 2006, 98(17):1183-1192. 16954471
6. Paik S Shak S Tang G Kim C Baker J Cronin M Baehner FL Walker MG Watson D Park T A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. The New England journal of medicine 2004 351 27 2817 2826 10.1056/NEJMoa041588 15591335
7. Michiels S Koscielny S Hill C Prediction of cancer outcome with microarrays: A multiple random validation strategy. Lancet 2005, 365(9458):488-492. 10.1016/S0140-6736(05)17866-0 15705458
8. Eden P Ritz C Rose C Ferno M Peterson C "Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers. Eur J Cancer 2004, 40(12):1837-1841. 10.1016/ j.ejca.2004.02.025 15288284
9. Ransohoff DF Bias as a threat to the validity of cancer molecular-marker research. Nature reviews 2005, 5(2):142-149. 10.1038/nrc1550 15685197
10. Ein-Dor L Kela I Getz G Givol D Domany E Outcome signature genes in breast cancer: Is there a unique set? Bioinformatics (Oxford, England) 2005, 21(2):171-178. 10.1093/bioinformatics/bth469 15308542
11. Ein-Dor L Zuk O Domany E Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(15):5923-5928. 1458674 16585533 10.1073/pnas.0601231103
12. Chang HY Nuyten DS Sneddon JB Hastie T Tibshirani R Sorlie T Dai H He YD van't Veer LJ Bartelink H Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(10):3738-3743. 548329 15701700 10.1073/ pnas.0409462102
13. van't Veer LJ Dai H van de Vijver MJ He YD Hart AA Mao M Peterse HL van der Kooy K Marton MJ Witteveen AT Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415(6871):530-536. 10.1038/415530a 11823860
14. Naderi A Teschendorff AE Barbosa-Morais NL Pinder SE Green AR Powe DG Robertson JF Aparicio S Ellis IO Brenton JD A gene-expression signature to predict survival in breast cancer across independent data sets. Oncogene 2007, 26(10):1507-1516. 10.1038/sj.onc.1209920 16936776
15. Sotiriou C Wirapati P Loi S Harris A Fox S Smeds J Nordgren H Farmer P Praz V Haibe-Kains B Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. Journal of the National Cancer Institute 2006, 98(4):262-272. 16478745
16. Pawitan Y Bjohle J Amler L Borg AL Egyhazi S Hall P Han X Holmberg L Huang F Klaar S Gene expression profiling spares early breast cancer patients from adjuvant therapy: Derived and validated in two population-based cohorts. Breast Cancer Res 2005, 7(6):R953-964. 1410752 16280042 10.1186/bcr1325
17. West M Blanchette C Dressman H Huang E Ishida S Spang R Zuzan H Olson JA Jr Marks JR Nevins JR Predicting the clinical status of human breast cancer by using gene expression profiles. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(20):11462-11467. 58752 11562467 10.1073/pnas.201162998
18. Sotiriou C Neo SY McShane LM Korn EL Long PM Jazaeri A Martiat P Fox SB Harris AL Liu ET Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(18):10393-10398. 193572 12917485 10.1073/pnas.1732912100
19. Miller LD Smeds J George J Vega VB Vergara L Ploner A Pawitan Y Hall P Klaar S Liu ET An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(38):13550-13555. 1197273 16141321 10.1073/ pnas.0506230102
20. Bild AH Yao G Chang JT Wang Q Potti A Chasse D Joshi MB Harpole D Lancaster JM Berchuck A Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006, 439(7074):353-357. 10.1038/ nature04296 16273092
21. Subramanian A Tamayo P Mootha VK Mukherjee S Ebert BL Gillette MA Paulovich A Pomeroy SL Golub TR Lander ES Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(43):15545-15550. 1239896 16199517 10.1073/ pnas.0506580102
22. Kim SY Volsky DJ PAGE: Parametric analysis of gene set enrichment. BMC bioinformatics 2005, 6:144. 1183189 15941488 10.1186/1471-2105-6-144
23. Goeman JJ Oosting J Cleton-Jansen AM Anninga JK van Houwelingen HC Testing association of a pathway with survival using gene expression data. Bioinformatics (Oxford, England) 2005, 21(9):1950-1957. 10.1093/ bioinformatics/bti267 15657105
24. Teschendorff AE Naderi A Barbosa-Morais NL Pinder SE Ellis IO Aparicio S Brenton JD Caldas C A consensus prognostic gene expression classifier for ER positive breast cancer. Genome biology 2006, 7(10):R101. 1794561 17076897 10.1186/gb-2006-7-10-r101
25. Perou CM Sorlie T Eisen MB van de Rijn M Jeffrey SS Rees CA Pollack JR Ross DT Johnsen H Akslen LA Molecular portraits of human breast tumours. Nature 2000, 406(6797):747-752. 10.1038/35021093 10963602
26. Sorlie T Perou CM Tibshirani R Aas T Geisler S Johnsen H Hastie T Eisen MB van de Rijn M Jeffrey SS Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(19):10869-10874. 58566 11553815 10.1073/pnas.191367098
27. Sorlie T Tibshirani R Parker J Hastie T Marron JS Nobel A Deng S Johnsen H Pesich R Geisler S Repeated observation of breast tumor subtypes in independent gene expression data sets. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(14):8418-8423. 166244 12829800 10.1073/pnas.0932692100
28. Dudoit S Fridlyand J Speed TP Comparison of discrimination methods for the classification of tumors using gene expression data. Journal of the American Statistical Association 2002, 97(457):77-87. 10.1198/ 016214502753479248
29. Whitfield ML George LK Grant GD Perou CM Common markers of proliferation. Nature Reviews Cancer 2006, 6(2):99-106. 10.1038/nrc1802 16491069
30. Fan C Oh DS Wessels L Weigelt B Nuyten DS Nobel AB van't Veer LJ Perou CM Concordance among gene-expression-based predictors for breast cancer. The New England journal of medicine 2006, 355(6):560-569. 10.1056/ NEJMoa052933 16899776
31. Chang JT Nevins JR GATHER: A systems approach to interpreting genomic signatures. Bioinformatics (Oxford, England) 2006, 22(23):2926-2933. 10.1093/bioinformatics/btl483 17000751
32. Simon R Development and evaluation of therapeutically relevant predictive classifiers using gene expression profiling. Journal of the National Cancer Institute 2006, 98(17):1169-1171. 16954463
33. Pepe MS Janes H Longton G Leisenring W Newcomb P Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. American journal of epidemiology 2004 159 9 882 890 10.1093/aje/kwh101 15105181
34. Ioannidis JP Is molecular profiling ready for use in clinical decision making? The oncologist 2007, 12(3):301-311. 10.1634/ theoncologist.12-3-301 17405894
35. Pepe MS Evaluating technologies for classification and prediction in medicine. Statistics in medicine 2005, 24(24):3687-3696. 10.1002/ sim.2431 16320261
36. Ioannidis JP Microarrays and molecular research: Noise discovery? Lancet 2005, 365(9458):454-455. 15705441
37. Reis-Filho JS Westbury C Pierga JY The impact of expression profiling on prognostic and predictive testing in breast cancer. J Clin Pathol 2006, 59(3):225-231. 10.1136/jcp.2005.028324 16505270
38. Weigelt B Hu Z He X Livasy C Carey LA Ewend MG Glas AM Perou CM Van't Veer LJ Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer research 2005, 65(20):9155-9158. 10.1158/0008-5472.CAN-05-2553 16230372
39. Gene expression omnibus (GEO) http://www.ncbi.nlm.nih.gov/GEO/
40. Stanford Microarray Database http://genome-www5.stanford.edu/
41. Oh DS Troester MA Usary J Hu Z He X Fan C Wu J Carey LA Perou CM Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers. J Clin Oncol 2006, 24(11):1656-1664. 10.1200/ JCO.2005.03.2755 16505416
42. The Gene Ontology http://www.geneontology.org
43. GenMAPP http://www.genmapp.org
44. KEGG: Kyoto Encyclopedia of Genes and Genomes http://www.genome.up/kegg/
45. InterPro http://www.ebi.ac.uk/interpro/
46. Affymetrix.
47. Kim SY Kim Y Genome-wide prediction of transcriptional regulatory elements of human promoters using gene expression and promoter analysis data. BMC bioinformatics 2006, 7:330. 1586028 16817975 10.1186/ 1471-2105-7-330
48. GEPAS: Gene Expression Pattern Analysis Suite http://gepas.bioinfo.cipf.es/
49. Vaquerizas JM Conde L Yankilevich P Cabezon A Minguez P Diaz-Uriarte R Al-Shahrour F Herrero J Dopazo J GEPAS, an experiment-oriented pipeline for the analysis of microarray gene expression data. Nucleic acids research 2005, 33: Web Server W616-620. 1160260 15980548 10.1093/nar/ gki500
50. The R Project for Statistical Computing http://www.r-project.org/
51. Python Programming Language http://www.python.org
52. Huang E Cheng SH Dressman H Pittman J Tsou MH Horng CF Bild A Iversen ES Liao M Chen CM Gene expression predictors of breast cancer outcomes. Lancet 2003, 361:9369-1590. 1596 10.1016/S0140-6736(03)13308-9 12747878
53. Zhao H Langerod A Ji Y Nowels KW Nesland JM Tibshirani R Bukholm IK Karesen R Botstein D Borresen-Dale AL Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Molecular biology of the cell 2004, 15(6):2523-2536. 420079 15034139 10.1091/ mbc.E03-11-0786
54. Glinsky GV Higashiyama T Glinskii AB Classification of human breast cancer using gene expression profiling as a component of the survival predictor algorithm. Clin Cancer Res 2004, 10(7):2272-2283. 10.1158/ 1078-0432.CCR-03-0522 15073102
55. Glinsky GV Berezovska O Glinskii AB Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. The Journal of clinical investigation 2005, 115(6):1503-1521. 1136989 15931389 10.1172/JCI23412
56. Schuetz CS Bonin M Clare SE Nieselt K Sotlar K Walter M Fehm T Solomayer E Riess O Wallwiener D Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Cancer research 2006, 66(10):5278-5286. 10.1158/0008-5472.CAN-05-4610 16707453